CCO Expert Recap

Clinical Updates in HBV Treatment

Source: CCO Independent Conference Coverage of the 2007 Annual Meeting of the American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Clinical Updates in HBV Treatment


Faculty:

Raymond T. Chung, MD
  • Raymond T. Chung, MD

CME CREDIT INFORMATION

Release Date: 01/07/08

Expiration Date: 01/06/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credits

Status: Please log in to view status


Begin the CCO Expert Recap

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss emerging efficacy and safety data on new agents for hepatitis B
  • Describe long-term treatment data on the management of hepatitis B
  • Summarize strategies for managing patients with resistance or suboptimal responses
  • Discuss factors associated with treatment outcomes in hepatitis B

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.

Related Content

Related Tracks from this CCO Independent Conference Coverage:

Update on Investigational Agents in HCV: 2007